Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oragenics Inc. Common Stock (NY:OGEN)

0.1200 -0.0124 (-9.37%)
Official Closing Price Updated: 8:00 PM EDT, May 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Oragenics Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women... 
Via Benzinga
23 Stocks Moving in Tuesday's Pre-Market Session
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update. NeuroBo Pharmaceuticals, Inc... 
Via Benzinga
Oragenics Extends Collaboration with NRC Canada For Omicron-Specific Vaccine
Oragenics Inc (NYSE: OGEN) has extended a licensing and collaboration agreement with the National Research Council of Canada (NRC) to enable Oragenics to pursue an... 
Via Benzinga
Why Did Oragenics Shares Skyrocket Tuesday?
Oragenics Inc. (NYSE:OGEN) shares skyrocketed higher Tuesday... 
Via Benzinga
Oragenics Extends Collaboration with the National Research Council of Canada to Develop Vaccine against the Omicron Variant
From Oragenics, Inc.
Via Business Wire
Oragenics to Participate in Virtual Fireside Chat Hosted by Alliance Global Partners
From Oragenics, Inc.
Via Business Wire
Oragenics Co-Authors a Publication Describing the Dual Mechanism of Action of Lantibiotics
From Oragenics, Inc.
Via Business Wire
Oragenics COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action
Oragenics Inc (NYSE: OGEN) announced the results from its hamster challenge study to evaluate the COVID-19 vaccine candidate. The study is assessing the... 
Via Benzinga
Exposures COVID-19
Oragenics Announces Positive COVID-19 Challenge Study Results Evaluating Multiple Formulations of its SARS-CoV-2 Vaccine Candidate
From Oragenics, Inc.
Via Business Wire
20 Stocks Moving In Tuesday's Pre-Market Session
Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) rose 117.3% to $4.78 in pre-market trading after the company announced the FDA approved expanded labeling for Caldolor to... 
Via Benzinga
Exposures Product Safety
Oragenics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
From Oragenics, Inc.
Via Business Wire
25 Stocks Moving in Tuesday's Pre-Market Session
Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 95.1% to $23.22 in pre-market trading after jumping around 24% on Monday. Diginex Limited (NASDAQ: EQOS) rose 74.5% to $7.... 
Via Benzinga
Oragenics Awarded a $250,000 Grant from the National Institute of General Medical Sciences (NIGMS) for the Continued Research and Development of Lantibiotics.
From Oragenics, Inc.
Via Business Wire
Oragenics Launches Animal Study For COVID-19 Vaccine Candidate
Oragenics Inc (NYSE: OGEN) has initiated a hamster challenge study to evaluate the immunogenicity and viral load reduction impact of its COVID-19 vaccine candidate... 
Via Benzinga
Exposures COVID-19
Oragenics Initiates COVID-19 Challenge Study Evaluating Multiple Formulations of its SARS-CoV-2 Vaccine Candidate
From Oragenics, Inc.
Via Business Wire
48 Biggest Movers From Yesterday
Gainers RenovoRx, Inc. (NASDAQ: RNXT) climbed 107.8% to close at $16.02 on Monday after the company was granted FDA clearance for ‘Catheter, Intravascular Occluding,... 
Via Benzinga
Exposures Product Safety
35 Stocks Moving In Monday's Mid-Day Session
Gainers Globalstar, Inc. (NYSE: GSAT) shares climbed 43.6% to $2.0535. GSAT shares traded higher following a note sent out by popular Apple Inc. (NASDAQ: AAPL) analyst Ming... 
Via Benzinga
Oragenics's New Preclinical Data Supports Its Approach For COVID-19 Vaccine Development
Oragenics Inc's (NYSE: OGEN) stabilized pre-fusion spike protein trimer generates neutralizing antibodies in mice after immunization against SARS-CoV-2 when... 
Via Benzinga
Exposures COVID-19
Oragenics’ SARS-CoV-2 Spike Protein Produces Neutralizing Antibodies in Mice with Intramuscular and Intranasal Adjuvants
From Oragenics, Inc.
Via Business Wire
Oragenics Announces Postponement of Annual Meeting of Shareholders
From Oragenics, Inc.
Via Business Wire
62 Biggest Movers From Yesterday
Gainers Flora Growth Corp. (NASDAQ: FLGC) surged 63.1% to close at $8.27. The Miami-based cannabis producer confirmed Tuesday it has signed a non-binding letter of intent to... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
50 Stocks Moving In Wednesday's Mid-Day Session
Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares jumped 59.9% to $2.43. Infinity Pharmaceuticals shares tumbled over 31% on Tuesday after the company highlighted the... 
Via Benzinga
28 Stocks Moving in Wednesday's Pre-Market Session
Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares rose 38.2% to $2.10 in pre-market trading. Infinity Pharmaceuticals shares tumbled over 31% on Tuesday after the... 
Via Benzinga
62 Biggest Movers From Yesterday
Gainers Intrusion Inc. (NASDAQ: INTZ) shares surged 52.1% to settle at $5.14 on Tuesday. Intrusion recently issued worse-than-expected preliminary Q2 sales results and announced... 
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Tumbles 240 Points; Oragenics Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded down 0.50% to 34,969.30 while the NASDAQ fell 1.62% to 14,600.30. The S&P also fell, dropping 0.80% to 4,387.07. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Mid-Day Market Update: GasLog Partners Drops After Q2 Results; EyeGate Pharmaceuticals Shares Jump
Midway through trading Tuesday, the Dow traded down 0.51% to 34,963.96 while the NASDAQ fell 1.85% to 14,565.52. The S&P also fell, dropping 0.81% to 4,386.41. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
44 Stocks Moving In Tuesday's Mid-Day Session
Gainers Oragenics, Inc. (NASDAQ: OGEN) surged 55.9% to $0.9749 after the company announced it entered into a licensing agreement with the National Research Council of Canada that... 
Via Benzinga
OGEN Stock: The Covid Vaccine News That Has Oragenics Shooting Higher Today
Oragenics (OGEN) stock is surging higher on Tuesday following news that the company is developing a new vaccine for the novel coronavirus. 
Via InvestorPlace
Exposures COVID-19
Oragenics Stock Is Trading Higher On Licensing, Material Transfer Pact For Rapid Development Of COVID-19 Vaccine
Oragenics Inc (NYSE: OGEN) has entered into a licensing agreement with the National Research Council of Canada (NRC), allowing Oragenics to develop next-generation... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.